Baystreet.ca – Soligenix Trumps Year-End Financials
Soligenix, Inc. (NASDAQ: SNGX) shares lost some steam early Friday, as the company, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where…
Read more